Patents by Inventor Erkki Nissinen

Erkki Nissinen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for pulmonary administration
    Publication number: 20050143361
    Abstract: An inhalation medicament comprising orazipone and a beta2-adrenoreceptor agonist and/or a corticosteroid as a combined preparation. Optionally the medicament also comprises one or more pharmaceutically acceptable additive, diluents or carriers. The beta-2adrenoreceptor agonist and the corticosteroid may comprise, respectively, formoterol and budesonide.
    Type: Application
    Filed: January 22, 2003
    Publication date: June 30, 2005
    Inventors: Pertti Happonen, Elina Serkkola, Erkki Nissinen
  • Anti-inflammatory agents
    Patent number: 6878702
    Abstract: The use of mitochondrial KATP channel openers, particularly compounds of general formula (I), for the treatment or prevention of inflammation by inducing apoptosis of inflammatory cells.
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: April 12, 2005
    Assignee: Orion Corporation
    Inventors: Heimo Haikala, Minja Hyttilä-Hopponen, Erkki Nissinen, Minna Ruotsalainen, Aino Pippuri, Kari Lönnberg
  • Anti-inflammatory agents
    Publication number: 20040029870
    Abstract: The invention relates to the use of mitochondrial KATP channel openers, particularly compounds of general formula (1), for the treatment or prevention of inflammation by inducing apoptosis or inflammatory cells.
    Type: Application
    Filed: September 11, 2003
    Publication date: February 12, 2004
    Inventors: Heimo Haikala, Minja Hyttila-Hopponen, Erkki Nissinen, Minna Ruotsalainen, Aino Pippuri, Kari Lonnberg
  • Pharmacologically active catechol derivatives
    Patent number: 6121303
    Abstract: A compound of formula I ##STR1## wherein R.sub.1 is nitro, halogeno or cyano group and R.sub.2 is a group selected from ##STR2## wherein Y and Z are independently oxygen, sulfur or NR, wherein R is hydrogen, straight or branched C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, phenylC.sub.1-8 alkyl or phenyl group and X.sub.1 and X.sub.2 are NR, where R is hydrogen, straight or branched C.sub.1-8 alkyl, C.sub.5-7 cycloalkyl, phenylC.sub.1-8 alkyl or phenyl group, or a pharmaceutically acceptable salt or ester thereof. Pharmaceutical compositions are also disclosed.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: September 19, 2000
    Assignee: Orion-yhtyma Oy
    Inventors: Reijo Backstrom, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen
  • Pharmacologically active catechol derivatives
    Patent number: 5889037
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 30, 1999
    Assignee: Orion-yhtyma Oy
    Inventors: Reijo Backstrom, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen
  • Pharmacologically active catechol derivatives
    Patent number: 5614541
    Abstract: New catechol derivatives and pharmaceutically acceptable salts and esters thereof useful as pharmaceutical antioxidants are disclosed. Cellular damage by oxygen derived radicals is a significant factor in heart disease, rheumatoid arthritis, cancer, inflammatory disease, transplant rejection reactions and ischemia.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: March 25, 1997
    Assignee: Orion-yhtym a Oy
    Inventors: Reijo B ackstr om, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen
  • Pharmacologically active catechol derivatives
    Patent number: 5362733
    Abstract: Compounds of formula(I) ##STR1## wherein R.sub.1 is nitro, halo, cyano and R.sub.2 is a group selected from ##STR2## wherein Y is oxygen or sulfur; X.sub.1 is NR wherein R is hydrogen, C.sub.1-8 alkyl or phenyl and pharmaceutically acceptable salts thereof are useful in the prevention or treatment of tissue damage induced by lipid peroxidation.
    Type: Grant
    Filed: October 23, 1992
    Date of Patent: November 8, 1994
    Assignee: Orion-yhtyma Oy
    Inventors: Reijo Backstrom, Erkki Honkanen, Inge-Britt Linden, Erkki Nissinen, Aino Pippuri, Pentti Pohto, Tapio Korkolainen